The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease
(2018)
Journal Article
Souza, C. K., Rajão, D. S., Sandbulte, M. R., Lopes, S., Lewis, N. S., Loving, C. L., Gauger, P. C., & Vincent, A. L. (2018). The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease. Vaccine, 36(41), 6103-6110. https://doi.org/10.1016/j.vaccine.2018.08.072
Influenza A virus (IAV) causes a disease burden in the swine industry in the US and is a challenge to prevent due to substantial genetic and antigenic diversity of IAV that circulate in pig populations. Whole inactivated virus (WIV) vaccines formulat... Read More about The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.